Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Cash from Investing Activities (2016 - 2025)

China Pharma Holdings filings provide 16 years of Cash from Investing Activities readings, the most recent being -$5767.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 97.89% to -$5767.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$137251.0, a 59.1% increase, with the full-year FY2025 number at -$137251.0, up 52.95% from a year prior.
  • Cash from Investing Activities hit -$5767.0 in Q4 2025 for China Pharma Holdings, up from -$40598.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $55964.0 in Q1 2023 to a low of -$415977.0 in Q3 2021.
  • Median Cash from Investing Activities over the past 5 years was -$8488.5 (2021), compared with a mean of -$77337.3.
  • Biggest five-year swings in Cash from Investing Activities: surged 4123.29% in 2023 and later tumbled 5927.21% in 2024.
  • China Pharma Holdings' Cash from Investing Activities stood at -$7056.0 in 2021, then skyrocketed by 486.45% to $27268.0 in 2022, then plummeted by 116.6% to -$4527.0 in 2023, then tumbled by 5927.21% to -$272852.0 in 2024, then surged by 97.89% to -$5767.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$5767.0 (Q4 2025), -$40598.0 (Q3 2025), and -$9921.0 (Q2 2025) per Business Quant data.